ERLOTINIB DERIVATIVES & USES THEREOF

The present invention relates to compounds useful in the treatment of cancers, in particular cancers overexpressing the epidermal growth factor receptor (EGFR) such as non-small cell lung or breast cancers.


Year:
2012
Patent number(s):
Laboratories:




 Record created 2012-01-17, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)